Cargando…
OnabotulinumtoxinA injections for atypical odontalgia: an open-label study on nine patients
BACKGROUND: Atypical odontalgia (AO) manifests as continuous pain in the region of one or several teeth, in the absence of signs of dental pathology. Currently, there is insufficient evidence to establish treatment guidelines for AO. The aim of this study was to describe the effectiveness and safety...
Autores principales: | García-Sáez, Rafael, Gutiérrez-Viedma, Álvaro, González-García, Nuria, Gómez-Mayordomo, Víctor, Porta-Etessam, Jesús, Cuadrado, María-Luz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112804/ https://www.ncbi.nlm.nih.gov/pubmed/30197533 http://dx.doi.org/10.2147/JPR.S169701 |
Ejemplares similares
-
OnabotulinumtoxinA infiltration and nerve blocks in patients with headache and neuralgia: safety recommendations to prevent SARS-CoV-2 infection()
por: Santos-Lasaosa, S., et al.
Publicado: (2020) -
Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections
por: Hermanowicz, Neal
Publicado: (2021) -
Biopsychosocial Aspects of Atypical Odontalgia
por: Ciaramella, A., et al.
Publicado: (2013) -
OnabotulinumtoxinA for Hemicrania Continua: open label experience in 9 patients
por: Miller, Sarah, et al.
Publicado: (2015) -
OnabotulinumtoxinA in the treatment of neurogenic bladder
por: Gulamhusein, Aziz, et al.
Publicado: (2012)